https://www.pharmacompass.com/ daily 1.00 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/3m-company yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abbott-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abbvie-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/acino-pharma-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/actavis-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/air-liquide-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alembic-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/allergan-aesthetics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alliance-medical-products-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ambiopharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amneal-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amoli-organics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amphastar-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amw-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/angelini-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/antibiotice yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/apotex-fermentation-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/apotex-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nectar-lifesciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aspen-pharmacare-holdings yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/assia-chemical-industries-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/astrazeneca yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aurobindo-pharma-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/b-braun-medical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/banner-pharmacaps-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bausch-lomb-incorporated yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/baxter-healthcare-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bayer-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/becton-dickinson yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/beximco-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biocon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioindustria-lim-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biopharma-srl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biovet-ad yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bluepharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/boehringer-ingelheim-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zydus-lifesciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/catalent-pharma-solutions yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chemi-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chemische-fabrik-berg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/church-dwight-co-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cipla yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/claris-lifesciences-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/colgate-palmolive yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/daiichi-sankyo yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/deva-holding-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dexcel-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dipharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dishman-netherlands-b-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-reddys-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/egis-pharmaceuticals-plc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/emcure-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/emd-millipore-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ethypharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmak-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fdc-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ferndale-laboratories-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ferring-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fertin-pharma-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/forest-laboratories-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-kabi-ab-brunna yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gador-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ge-healthcare-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gsk yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gp-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/grindeks-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ferrer-internacional yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hameln-pharma-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/helsinn-advanced-synthesis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hemofarm-a-d yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hetero-drugs yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hikma-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hisamitsu-pharmaceutical-co-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hospira-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hybio-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/indoco-remedies-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/intas-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ipca-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/istituto-biochimico-italiano-giovanni-lorenzini-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/italfarmaco-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ivax-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/janssen-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jubilant-generics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/krka yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/perrigo-company-plc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratoires-besins-international yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorio-reig-jofre-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/grifols-international yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-leon-farma-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-liconsa-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-normon-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laurus-labs yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lotus-pharmaceutical-co-ltd-nantou-plant yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lts-lohmann-therapie-systeme yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lupin-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/macleods-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mallinckrodt-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/meda-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medichem-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merck-co yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/micro-labs-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/msn-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mundipharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/viatris yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nanjing-king-friend-biochemical-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novartis-pharmaceuticals-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novartis-vaccines-and-diagnostics-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/olpha yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/olon-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orion-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/patheon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pfizer-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmachemie-b-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmacosmos-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/piramal-enterprises-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pliva-hrvatska yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/przedsiebiorstwo-farmaceutyczne-jelfa-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/qilu-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ranbaxy-laboratories-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/recipharm-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/recordati yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/reliance-life-sciences-private-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/resolution-chemicals-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rivopharm-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-farmaceuticos-rovi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sandoz-b2b yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sanochemia-pharmazeutika-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/euroapi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sc-infomed-fluids-srl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/serum-institute-of-india yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shenzhen-techdow-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/siegfried-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sintetica-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sun-pharmaceutical-industries-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/synthon-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/teva-pharmaceutical-industries yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tolmar yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/torrent-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ucb-pharma-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/umedica-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/unimark-remedies-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/unique-biotech-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/urquima-sa-grupo-uriach yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/usv-private-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bausch-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/warner-chilcott-company-llc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/wockhardt yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/xellia-pharmaceuticals-aps yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/yonsung-fine-chemicals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zambon-switzerland yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zentiva yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zhejiang-huahai-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zhuhai-united-laboratories-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/centrient-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/doc-generici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/inova-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/molnlycke-health-care-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/seqirus yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/menarini yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/obvius-investment-bv yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/extrovis-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/stallergenes-greer yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/agc-biologics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/basilea-pharmaceutica yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biofrontera yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biontech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/curium-us-llc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chong-kun-dang-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medytox yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hugel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/venus-remedies yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/genetix-biotherapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmamar yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/genmab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bavarian-nordic yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nabriva-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/heron-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cosmo-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/agios-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biocryst-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cycle-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/deciphera-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/viofar-pharmaceutical-cosmetical-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/formycon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/krystal-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merus yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mirum-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alk yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/csl-vifor yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioeq-ip-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biofarm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bridgebio-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mediwound yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/qbiotics-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/clinuvel-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/marinus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medivir yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/oncopeptides yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/outlook-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/uniqure yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kalvista-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/otsuka-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/geron yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/towa-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/galderma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ab-science yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novavax yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/stemline-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/taiho-oncology yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hansa-biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/berlin-chemie yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/norgine yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vectans-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/inflarx yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abigo-medical-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/arcturus-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/inceptua-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ology-bioservices yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aj-vaccines yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rhythm-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/partner-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/horus-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biogaran yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alfasigma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/diurnal-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biopharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aldo-union yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/oasmia-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/piramal-critical-care yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neurocrine-biosciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lfb yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/niox yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tobio-novelfarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/winthrop-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/camurus yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hartmann yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sesderma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/madrigal-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sinovac-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/porton-biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kedrion yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharming yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/afyx-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/insmed yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/r-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aspargo-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/stada-arzneimittel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/strongbridge-biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neovii yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chiesi-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bharat-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/napp-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hyloris-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/spirig-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dompe-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cassiopea yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/adalvo yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vericel-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/isotope-technologies-munich yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/telix-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/evive-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/exeltis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/croma-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alimera-sciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sedana-medical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/centus-biotherapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/epipharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gan-lee-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/waverley-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fulton-medicinali-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aspen-global-incorporated yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lachifarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/primex-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lfm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amryt-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/juvise-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/travere-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ibn-savio yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/endo-international yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lobsor-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/swixx-biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/effrx-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/coc-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medreich yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sol-spa-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/om-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/janssen-cilag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-serra-pamies yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tedec-meiji-farma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/europharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sifi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/linde yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/desitin-arzneimittel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medical-developments-international yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cp-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/delbert-lab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/adienne yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/advanced-accelerator-applications yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biomed yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/upsa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ecopharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/euro-lifecare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-alter yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mip-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/polisano-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/intrapharm-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/heumann yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioorganic-solution yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/diagnostic-green-llc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/intracare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-hipra yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/leadiant-biosciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/linepharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/macopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mendeli-kabs yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/messer yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lxo-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharma-stulln yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/serb yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/consilient-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merz-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/agio-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zschimmer-schwarz yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eczacba-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hameln-rds yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-vinas yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biotest yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aop-orphan yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biovail-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/petrovax yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/steba-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/heel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hnseler yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mcneil-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rosemont yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/schwabe-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/advanz-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alpinamed yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biovet yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dongkook-lifescience yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gebro-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratori-baldacci yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/max-zeller-soehne yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/klaria-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/devatis-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orion-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bbraun yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pari yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/secura-bio yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/glenwood yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lindis-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/curatis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hetero-biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ibsa-institut-biochimique yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/advicenne yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tiefenbacher-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abx-advanced-biochemical-compounds yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/organon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmitalia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/edmond-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/althera yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amivas yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/audevard-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sanofi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/waymade yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/scholl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vetpharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cz-vaccines yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/msd-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioglan yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/currax yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novelgenix yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cisbio yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/franklin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmaq yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/polifarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medartuum yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ics-eurofarmaco yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lcm-middle-east yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/endoceutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/essential-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/blue-earth-diagnostics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/spa-antibiotic-products yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/herbion yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/general-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chemvet yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ncpc-international-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/galepharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tenshi-kaizen yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/binnopharm-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/a-menarini yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dne-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/arrotex-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/interpharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vita-bee-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/materia-medica-holding yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jewim-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mabxience yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/smartpractice yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rayner yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mylan-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merz-aesthetics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/avogel-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jurabek-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tq-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/infectopharm-drugs-and-consilium yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orphalan yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bio-products-laboratory yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ennogen-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/morningside-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/arafarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cantabria-labs yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mabo-farma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tulip-lab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sunglow-lifescience yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/blumont-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/renata-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/belmedpreparaty yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aop-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eladum-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lekpharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/isdin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/univar-solutions yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/haleon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-ern yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmanovia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/triviumvet yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tetris-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/crescent-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mana-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/steriscience yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laurus-generics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/geropharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/karo-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/frilab-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/beacon-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/acucort yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/procare-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/as-kevelt yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/floris yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/universal-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mesoestetic-pharma-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medicom-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/techdow-usa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novofarm-biosyntez yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hasten-biopharmaceutic yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/drogsan-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eugia-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/norit-activated-carbon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/agepha-pharma-us yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharma-nova-medicine yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eurocept-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/life-molecular-imaging yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medi-radiopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharma-nordic yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/wockhardt-uk yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vetviva-richter yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hope-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chiesi-australia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medix yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/saba-la-sanayii-ve-ticaret yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ria-generics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/phoenix-labs yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/3m-health-care yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratoires-bailleul yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pascoe-natural-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/multimin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/strides-pharma-science yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/antistress-ag-burgerstein-vitamine yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/avalon-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/human-biome-institute yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/genesis-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nabros-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/promedcs-praha yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/streuli-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medice-health-family yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medice-pharma-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/averoa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/immedica-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/navamedic yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lacer yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/theravia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/2care4 yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abacus-medicine yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aesculapius-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/campus-pharma-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/carinopharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/almus yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bruno-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/andreabal yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/anpharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/anseris-farma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kalcex yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/1-a-pharma-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/brown-burk yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abz-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bb-farma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/agips-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aliud-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aco-hud-nordic yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ledins yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biomo-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biokanol-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biomedica-foscama yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alfa-intes-industria-terapeutica-splendore yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/betapharm-arzneimittel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dermapharm-holding yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-falk-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/drossapharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/difa-cooper yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ebb-medical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ecupharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/effik-italia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/doetsch-grether yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eg-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/epifarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/double-e-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-loges-co yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-friedrich-eberth-arzneimittel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hcs yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/haemato yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gmm-farma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/germed yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/genetic-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gekofar yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eql-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/errekappa-euroterapici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farto-srl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmavox yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmed yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/erol-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/firma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/exelgyn yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eurospital yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmaceutici-damor yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farma-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/labatec-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/diaco-biofarmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-kade-pharmazeutische yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fairmed-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/icn-polfa-rzeszw yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/idi-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/infirst-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/istituto-lusofarmaco-ditalia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/italian-devices yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/itc-farma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jemopharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/just-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/konpharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kwizda-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratori-guidotti yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lifepharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vitabalans yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/teofarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tilman yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/wrwag-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/monico yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neopharmed-gentili yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mepha-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/leyh-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lucane-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/wick-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/visufarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/voco yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medical-valley-invest yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/valeas yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tecnopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/stewart-italia-chemical-parmaceutical-industries yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/splendris-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sophos-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sosepharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medreg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mibe-gmbh-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mimer-medical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sf-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/scharper yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lagap yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/macure-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/omnivision yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rottapharm-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medinova yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/new-pharmashop yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/niconovum yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nordic-drugs yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nordmedica yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/otsuka-novel-products yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/passau-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratoires-expanscience yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mayoly-spindler yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lampugnani-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lanova-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/life-medical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/louis-widmer yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/malesci-istituto-farmacobiologico yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medic-italia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medifarm-italia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medlite yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rex-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rechon-life-science yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/renapharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neurim-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rowex yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/salmon-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/scanpharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/siar-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharma-nord yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tad-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorio-farmaceutico-sit yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/protina-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/proge-farm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pro-health-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pool-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/poa-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmaber-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orpha-swiss yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orkla yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/omikron-italia yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/morganceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/danhson yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sr-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/noucor yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/asamedic yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aspire-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amman-pharmaceutical-industries yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orphelia-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmascience yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/basi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jordanian-pharmaceutical-manufacturing yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medicus-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cnx-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/curateq-biologics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/verfora yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/opella-healthcare-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mercury-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/reva-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/denk-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sciclone-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/synbias-pharma-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alkaloids-bioactives-private-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/avia-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/brepco-biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vian yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kowa-company yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/leti-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorio-elea yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jsc-valenta-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kyiv-vitamin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biolitec yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bosnalijek yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biofarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/corza-medical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/engelhard-arzneimittel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/getz-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hac-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hal-allergy yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medicem yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/woerwag-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/h-lundbeck-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ever-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lavipharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kyowa-kirin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ddd-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bgp-group-of-companies yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cooper-lab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nordic-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/opko-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jiangsu-chia-tai-tianqing-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/f-hoffmann-la-roche yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eisai yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-se-co-kgaa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/roche-diagnostics-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-kabi-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-kabi-austria yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-kabi-norge-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-kabi-oncology-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-medical-care-de-mexico yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fresenius-medical-care yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/glenmark-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mitsubishi-tanabe-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merck-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merck-sante-sas yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sanitas-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharma-tech-industries yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/procter-gamble-chemicals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lek-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/elc-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/archimedis-healthcare-private-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bluefish-pharmaceuticals-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioprojet-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lipomed-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bionorica-se yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gracure-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alexion-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alfasan-international-bv yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/beiersdorf-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alliance-pharmaceutical-company yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alk-abello-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/almirall yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/atnahs-pharma-uk-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/beaphar-b-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/carefusion-canada-ulc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/celltrion yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ceva-animal-health-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chanelle-pharmaceuticals-manufacturing-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cheplapharm-arzneimittel-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/correvio-uk-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dechra-veterinary-products-a-s yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/delaval-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dopharma-b-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eco-animal-health-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/emdoka-bvba yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eurovet-animal-health-b-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/huvepharma-ad yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratoires-thea yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/les-laboratoires-du-saint-laurent-e-h-ltee yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lincoln-medical-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/linde-canada-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novartis-consumer-health-canada-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/octapharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/omrix-biopharmaceuticals-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/paxvax-berna-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmaq-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmazeutische-fabrik-montavit-ges-m-b-h yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/prestige-consumer-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/recordati-rare-diseases yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/schulke-mayr-g-m-b-h yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/smith-nephew-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/the-mentholatum-company-of-canada-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/thornton-ross-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/univet-pharmaceuticals-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vetoquinol-n-a-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/virbac yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vitalaire-canada-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pfizer-consumer-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zim-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioton-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmatex-italia-s-r-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fisiopharma-s-r-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/iasis-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ibss-biomed yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/antibiotic-razgrad-ad yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/phagecon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/krewel-meuselbach yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shin-poong-pharm-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alfred-e-tiefenbacher-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alpex-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/centurion-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/onko-kocsel-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/schaper-brummer-gmbh-co-kg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/seacross-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/torrefarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cinfa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/unimed-pharm-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/giuliani yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zoetis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bene-arzneimittel-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/adare-pharma-solutions yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/seid-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cadila-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/humanis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jw-pharmaceutical-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/grupo-farmasierra-s-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cz-pharma-s-r-o yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biofarma-pharmaceutical-industry-and-commerce-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/divasa-farmavic-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/esparma-pharma-services-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eumedica-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/f-trenka-chem-pharm-fabrik-ges-m-b-h yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/galenica-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gap-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gm-pharmaceuticals-ge-georgi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/grupo-juste yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hc-clover-productos-y-servicios-sl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aculife-healthcare-pvt-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/altan-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ananta-medicare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aristo-pharma-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/berko-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biodue-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biofarm-sp-z-o-o-pl-poland yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bruschettini-s-r-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cisen-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jgl-dd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/labiana-life-sciences-s-a-u yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-salvat yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lupin-europe-ltd-gb yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/minskintercaps-u-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/piam-farmaceutici-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/riemser-pharma-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/luye-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shandong-qidu-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sidefarma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/solvay yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/walter-ritter-gmbh-co-kg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/arterium-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/emergent-biosolutions yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmsol-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/regeneron-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dipharma-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biodeal-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmacenter yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merck-millipore yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gl-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/trimb-healthcare-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zeta-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/norameda yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pls-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zaphyr-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novocat-farma-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/samsung-bioepis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mithra-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tillomed-laboratories-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/delorbis-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/generis-farmaceutica-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aguettant yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zealand-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/indivior yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kite-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cstone-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/blueprint-medicines yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ascendis-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aryogen-pharmed yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amicus-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/theramex yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ptc-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biomed-lublin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/beone-medicines yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/k24-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/urgo-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/immunomedics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/springworks-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/siga-technologies yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/valneva yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/besins-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shield-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/verastem-oncology yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orchard-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/moderna-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/phytopharm-kleka-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/iovance-biotherapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orifarm-group-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ratiopharm-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/axapharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/santhera-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/idorsia-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/immunocore yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/inca-pharm-srl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/paranova-group-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/evolan-pharma-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aimmune-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/argenx yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vbi-vaccines yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alnylam-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/akcea-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neuraxpharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/evolus yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sumar-biotech yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/prestige-biopharma-pte-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/polfa-tarchomin-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/accord-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/acom yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/acorda-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aegerion yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alcon-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amarin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amgen-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/apogepha-arzneimittel-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bial yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bimeda-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioalliance-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biocodex yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biogen yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biomarin-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biosyn-arzneimittel-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bles-biochemicals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bracco yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bristol-laboratories-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cephalon-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chemo-iberica-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chiesi-usa-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/clinigen-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/clonmel-hlthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/covis-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/csl-behring yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/csl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/debiopharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dentsply-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/durata-theraps-intl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eckert-ziegler-strahlen yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eisai-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/faes-farma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/galderma-labs-lp yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/galen-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/geistlich-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/genthon-bv yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/guerbet yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gw-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hexal-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hra-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/imax-diagnostic-imaging-holding-limited-hk-hong-kong yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/incyte-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ipsen yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ire-elit yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/jazz-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratoire-theramex yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/esteve-quimica yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lyomark-pharma-gmbh-de-82041-oberhaching-near-munick yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medac-gesellschaft-fur-klinische-spezialpraparate-mbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/the-medicines-company yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medtronic-plc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/moberg-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/naprod-life-sciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/navidea-biopharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nippon-fine-chemical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nova-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/novo-nordisk yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nycomed-austria-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orphan-europe-sarl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pacira-biosciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/paion-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmaxis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/photocure yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pierrel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pinnacle-biologics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pohl-boskamp yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/procter-and-gamble yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/prostrakan-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/provepharm-life-solutions yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/questcor-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/reckitt-benckiser yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sanquin yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/santen-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-willmar-schwabe-extracta yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/septodont-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shionogi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shire-plc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sigma-tau yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/stiefel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/swedish-orphan-biovitrum-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/taiho-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tamarang yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/therakos yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/theratechnologies yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/theravance-biopharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ultragenyx-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/united-therapeutics yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vanda-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vertex-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/viiv-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vivus yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/wyeth-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zambon-group-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abc-farmaceutici-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abdi-ibrahim yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/abiogen-pharma-s-p-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/acic-europe-api-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/adamed-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aenova-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alkaloid-ad-skopje yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alkalon-a-s yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alta-care-laboratoires yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/alvogen yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/amdipharm-mercury-company-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/anfarm-hellas-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aqvida-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/aspen-api yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/astellas-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/atabay yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/athena-pharmaceutiques yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/azad-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/b-braun-melsungen-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/basf yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biem-ilac-san-ve-tic-as yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biocad yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/biologici-italia-laboratories-srl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bioveta-a-s yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/bristol-myers-squibb yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cardinal-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/celgene-corporation yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/centro-de-estudos-biofarmaceuticos-ltda yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/chanelle-medical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cinnagen-co yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/colep-laupheim-gmbh-co-kg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/consolidated-packaging-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cooper-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cordenpharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/covex yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/cyndea-pharma-sl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/demo-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/disphar-international-b-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-august-wolff-gmbh-co-kg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/dr-r-pfleger-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/elanco yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/eli-lilly yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/elpen-pharmaceutical-co-inc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/esseti-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmak-jsc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmalider-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmaprojects-sau yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/farmigea yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fidia-farmaceutici-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/finzelberg-gmbh-co-kg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/francia-farmaceutici-s-r-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/galenica-ma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/galenicum yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gedeon-richter yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/geiser-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/genepharm-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/gilead-sciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/grunenthal yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/grupo-azevedos yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hasco-lek yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hec-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/helba-ilac-ic-ve-dis-san-tic-ltd-sti yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/helm-portugal yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/help-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hennig-arzneimittel yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hermes-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/hubei-yitai-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/idifarma-des-farmaceutico-s-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ilko-ilac-sanayi-ve-ticaret-a-s yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/indar yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/johnson-johnson yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kern-pharma-s-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/kusum-healthcare-pvt-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/labiana-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/servier yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorio-farmaceutico-c-t-s-r-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-basi yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/laboratorios-calier yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rubio-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lambda-therapeutic-research-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lamda-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/leo-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lg-life-sciences yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/lisapharma-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/m-a-pharmachem-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mayne-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mc-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/mcneil-consumer-health yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medac yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medinfar yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medipha-sante yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medis-ehf yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/medochemie-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/merck-serono yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/methapharm-speciality-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/midas-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/molteni-farmaceutici yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/naari yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nanogen-pharmaceutical-biotechnology yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neogen-n-v yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/neutec-ilac-san-tic-a-s yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/nobel-ilac-sanayii-ve-ticaret-a-s yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/norbrook-laboratories yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/normon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ntc yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/omega-laboratories-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/orofino-pharmaceuticals-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/otsuka-chemical-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pannon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/panpharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pensa-pharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmacare-premium yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharmathen-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pharos-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pierre-fabre yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/pinewood-healthcare yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/polichem-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/polpharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/prasfarma-s-l yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/prjsc-indar yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/proteus yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/q-pharma-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rafarm-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/reig-jofre-group yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/rontis yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/s-a-l-f-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/s-c-rompharm-company-srl yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/serumwerk-bernburg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shandong-kexing-bioproducts yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/fosun-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shenyang-sunshine-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shijiazhuang-lonzeal-pharmac-co-ltd yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/shijiazhuang-no-4-pharmaceutical-co-lt yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sichuan-kelun-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/smb-laboratories-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/sofar-spa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/solvay-chemicals-international-s-a yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/stragen-pharma-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/stravencon yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/substipharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/swiss-parenterals-limited yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/takeda-pharmaceutical yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tecnimede yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/tillotts-pharma-ag yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/unimedic-ab yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/unipharma yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/uni-pharma-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/unither-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/uquifa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/ursapharm-arzneimittel-gmbh yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vefa-ilac yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vem-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/venipharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vinas yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/vioser-sa yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/welding-gmbh-co-kg yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/world-medicine yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/yuria-pharm yearly 0.7 https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/zaklady-farmaceutyczne-unia yearly 0.7